Foreign Institutional Investor (fii)

Agrawal also believed the current outflows may continue in the near term with the same intensity.

Life after 40,000 on Sensex may not be smooth: Experts

Normally, posts such as rallies market consolidate. So one should wait for correction near to 10600 levels to reenter in the market. Even one should take some money out from the table to reinvest on the downside.

Foresee two Fed rate hikes by end of year, none in June: UBS

Geoffrey Dennis of UBS believes the Fed is likely to hike only by September and then later on in December.

Worst maybe over; Nifty unlikely to go below 6800: Madhu Kela

Madhu Kela of Reliance Capital is of the opinion that market currently is looking stable and worst seems to be over. He feels market seems to have put a bottom in place for 2016-17 at around 6800-6900 and it is unlikely that these levels will be.

Objective to take FDI under automatic route to 95-96%: Kant

In an exclusive conversation with CNBC-TV18's Shereen Bhan, DIPP Secretary Amitabh Kant spoke on the government‘s decision to liberalise foreign direct investment policy in various sectors.

Equities look good from three-year perspective: ICICI Pru

It is a good time for long-term investors but a very confusing one for short-term traders is the word coming in from S Naren CIO, ICICI Prudential AMC.

See near-term range for rupee between 62-63/USD: HDFC Bank

Ashutosh Raina, Head of FX Trading at HDFC Bank in an interview to CNBC-TV18 spoke about reasons for the some strength on the rupee and its near-term range.

Economic issues, leadership main election planks: Jaitley

Arun Jaitely said the every member of the finance committee, which is headed by BJP's Yashwant Sinha, is opposed to raising foreign investment cap in insurance to 49 percent from the current 26 percent.

Uptrend intact; pvt banks, pharma good: Phillip Capital

For the index to touch 6100, Reliance Industries, Infosys and TCS will have to perform, says Vineet Bhatnagar opf Phillip Capital. He is bullish on private banks and pharmaceutical shares, and sees a positive build up in Tata Motors and Hero Motocorp.